Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance

被引:2
|
作者
Ding, Wu [1 ,2 ]
Ruan, Guodong [1 ]
Lin, Yingli [3 ]
Zhu, Jianming [1 ]
Li, Zhian [1 ]
Ye, Dengfeng [1 ]
机构
[1] Shaoxing Second Hosp, Dept Oncol Surg, Shaoxing, Peoples R China
[2] Shaoxing Univ, Sch Med, Dept Clin Med, Shaoxing, Peoples R China
[3] Shaoxing Vocat & Tech Coll, Dept Early Childhood Educ, Shaoxing, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
papillary thyroid carcinoma; low-risk; active surveillance; IPTW; PSM; NODE-METASTASIS; TASK-FORCE; IN-SITU; MICROCARCINOMA; SURGERY; CANCER; PROGRESSION; ASSOCIATION; MANAGEMENT; FEATURES;
D O I
10.3389/fendo.2023.1235006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThis study aims to compare the outcomes of active surveillance (AS) in low-risk papillary thyroid carcinoma (PTC) patients with different tumor sizes and lymph node metastasis status, in order to establish appropriate management strategies. By analyzing these results, this study provides valuable insights for the effective management of such patients, addressing the issues and challenges associated with AS in practical clinical practice.MethodsThe study utilized the SEER database supported by the National Cancer Institute of the United States, extracting data of PTC diagnosed between 2000 and 2015. Statistical analyses were conducted using inverse probability weighting (IPTW) and propensity score matching (PSM), including Kaplan-Meier survival curves and Cox regression models, to evaluate the impact of different tumor sizes and lymph node metastasis status on thyroid cancer-specific survival (TCSS).ResultsA total of 57,000 PTC patients were included, with most covariates having standardized mean differences below 10% after IPTW and PSM adjustments. The TCSS of PTC with a diameter smaller than 13mm is significantly better than that of tumors with a diameter larger than 13mm, regardless of the presence of lymph node metastasis. Among PTC cases with a diameter smaller than 13mm, the TCSS of patients is similar, regardless of the presence of lymph node metastasis. However, in PTC cases with a diameter larger than 13mm, the presence of lateral neck lymph node metastasis (N1b stage) significantly impacts the TCSS, although the absolute impact on TCSS rate is minimal.ConclusionThe treatment strategy of AS is safe for patients with T1a stage papillary thyroid microcarcinoma (PTMC). However, for patients with T1b stage, if the tumor diameter exceeds 13mm or there is lymph node metastasis in the lateral neck region, the TCSS will be significantly affected. Nevertheless, the absolute impact on survival is relatively small.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea
    Lee, Eun Kyung
    Moon, Jae Hoon
    Hwangbo, Yul
    Ryu, Chang Hwan
    Cho, Sun Wook
    Choi, June Young
    Chung, Eun-Jae
    Jeong, Woo-Jin
    Jung, Yuh-Seog
    Ryu, Junsun
    Kim, Su-jin
    Kim, Min Joo
    Kim, Yeo Koon
    Lee, Chang Yoon
    Lee, Ji Ye
    Yu, Hyeong Won
    Hah, Jeong Hun
    Lee, Kyu Eun
    Lee, You Jin
    Park, Sue K.
    Park, Do Joon
    Kim, Ji-hoon
    Park, Young Joo
    THYROID, 2022, 32 (11) : 1328 - 1336
  • [42] The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?
    Liu, Wen
    Yan, Xuejing
    Cheng, Ruochuan
    CANCER BIOLOGY & MEDICINE, 2022, 19 (05) : 619 - 634
  • [43] Thirty years of active surveillance for low-risk thyroid cancer, lessons learned and future directions
    Smulever, Anabella
    Pitoia, Fabian
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2024, 25 (01): : 65 - 78
  • [44] Active surveillance for low-risk bladder cancer
    Tiu, Albert
    Jenkins, Lawrence C.
    Soloway, Mark S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 33.e7 - 33.e10
  • [45] Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America
    Smulever, Anabella
    Pitoia, Fabian
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2019, 63 (05): : 462 - 469
  • [46] Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience
    Miyauchi, Akira
    Ito, Yasuhiro
    Fujishima, Makoto
    Miya, Akihiro
    Onoda, Naoyoshi
    Kihara, Minoru
    Higashiyama, Takuya
    Masuoka, Hiroo
    Kawano, Shiori
    Sasaki, Takahiro
    Nishikawa, Mitsushige
    Fukata, Shuji
    Akamizu, Takashi
    Ito, Mitsuru
    Nishihara, Eijun
    Hisakado, Mako
    Kosaka, Kazuyoshi
    Hirokawa, Mitsuyoshi
    Hayashi, Toshitetsu
    THYROID, 2023, 33 (07) : 817 - 825
  • [47] Management of Low-Risk Papillary Thyroid Cancer
    Iniguez-Ariza, Nicole M.
    Brito, Juan P.
    ENDOCRINOLOGY AND METABOLISM, 2018, 33 (02) : 185 - 194
  • [48] Active surveillance for adult low-risk papillary thyroid microcarcinoma-a review focused on the 30-year experience of Kuma Hospital-
    Ito, Yasuhiro
    Miyauchi, Akira
    Fujishima, Makoto
    Yamamoto, Masashi
    Sasaki, Takahiro
    ENDOCRINE JOURNAL, 2024, 71 (01) : 7 - 21
  • [49] A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer
    Sawka, Anna M.
    Ghai, Sangeet
    Yoannidis, Tom
    Rotstein, Lorne
    Gullane, Patrick J.
    Gilbert, Ralph W.
    Pasternak, Jesse D.
    Brown, Dale H.
    Eskander, Antoine
    de Almeida, John R.
    Irish, Jonathan C.
    Higgins, Kevin
    Enepekides, Danny J.
    Monteiro, Eric
    Banerjee, Avik
    Shah, Manish
    Gooden, Everton
    Zahedi, Afshan
    Korman, Mark
    Ezzat, Shereen
    Jones, Jennifer M.
    Rac, Valeria E.
    Tomlinson, George
    Stanimirovic, Aleksandra
    Gafni, Amiram
    Baxter, Nancy N.
    Goldstein, David P.
    THYROID, 2020, 30 (07) : 999 - 1007
  • [50] A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer
    Sawka, Anna M.
    Ghai, Sangeet
    Rotstein, Lorne
    Irish, Jonathan C.
    Pasternak, Jesse D.
    Gullane, Patrick J.
    Monteiro, Eric
    Gooden, Everton
    Brown, Dale H.
    Eskander, Antoine
    Zahedi, Afshan
    Chung, Janet
    Su, Jie
    Xu, Wei
    Ihekire, Ogemdi
    Jones, Jennifer M.
    Gafni, Amiram
    Baxter, Nancy N.
    Goldstein, David P.
    THYROID, 2022, 32 (03) : 255 - 262